Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.33% vs 18.71% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 410.25% vs 221.59% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -34.73% vs 681.43% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 125.00% vs -60.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Tianjin Lisheng Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.33% vs 18.71% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.64% vs 18.30% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 410.25% vs 221.59% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 536.12% vs 3.89% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -34.73% vs 681.43% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -39.39% vs 26.12% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 125.00% vs -60.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.50% vs 300.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






